INHALED NITRIC OXIDE MARKET Challenges and Opportunities

Inhaled Nitric Oxide Market, By Product Type (Inhaled Nitric Oxide Delivery Systems, Consumables, (Nitric Oxide Cylinders and Delivery Accessories), and Others), By Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), acute respiratory distress syndrome (ARDS), Tuberculosis Treatment, Malaria Treatment, and Others), By Strength (100 ppm, 800 ppm, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Home Care Settings), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Feb 2025
Code : CMI7478
Pages :140
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenge - High costs associated with inhaled nitric oxide therapy

A major challenge in the inhaled nitric oxide market is the high cost of therapy, which includes complex delivery systems, gas handling equipment, and expensive gas itself. Annual costs per patient range from US$ 30,000 to US$ 50,000, with one treatment averaging over US$ 1,000. This financial burden limits adoption, especially in price-sensitive markets. Reducing equipment and operational costs through innovation is crucial to making INO therapy more accessible and driving long-term market growth.

Market Opportunity- Strategic partnerships drive inhaled nitric oxide market growth

Strategic partnerships in the inhaled nitric oxide market offer substantial growth opportunities by integrating expertise, resources, and technologies to enhance product portfolios. For instance, October 2, 2024, Beyond Air, a medical device and biopharmaceutical company, partnered with Healthcare Links, a healthcare advisory and contracting firm, to expand the availability of its LungFit PH system, a groundbreaking inhaled nitric oxide (NO) generator and delivery system.

INHALED NITRIC OXIDE MARKET Challenges and Opportunities

Inhaled Nitric Oxide Market Report Snapshots

EXISTING CLIENTELE